Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Metalsguy1on Apr 15, 2021 12:13pm
101 Views
Post# 33000969

RE:RE:Getting past Assumptions

RE:RE:Getting past Assumptions
@Red the old adage that "you learn from your mistakes" is woefully outdated and a relatively recent scientific study debunked it. People learn a great deal more from success than failure. The failure to close a financially significant deal in the last 3 years clearly shows that no one at the company has learned from their mistakes. For goodness sakes how many times in the last few years have investors here expressed everything from consternation to disgust over dilutive poorly funded deals, rumors of imminent deals that never materialize, drive by trials where companies get to test drive the pouch without making any commitments that demonstrate confidence to the market. Yet again we have collaborations with no benefit accruing to the company and the mother of all dilutive deals, fluff news, no plan, no vision, just recycling of news and fluff. Witkowski is the only person holding up the share price. NO ONE HAS LEARNED A THING, except the shareholders.
<< Previous
Bullboard Posts
Next >>